((structured treatment interruptions and hiv) AND (randomized controlled trial[Publication Type] OR (randomized[Title/Abstract] AND controlled[Title/Abstract] AND trial[Title/Abstract]))) AND (randomized controlled trial[Publication Type] OR (randomized[Title/Abstract] AND controlled[Title/Abstract] AND trial[Title/Abstract]))

Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection: A Substudy of the ANRS 106 Window Trial.

Charreau I, Jeanblanc G, Tangre P, Boyer L, Saouzanet M, Marchou B, Molina JM, Aboulker JP, Durand-Zaleski I; and the ANRS 106 Study Group.

J Acquir Immune Defic Syndr. 2008 Oct 16. [Epub ahead of print]

PMID: 18931625 [PubMed - as supplied by publisher]

Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infection.

Lewin SR, Murray JM, Solomon A, Wightman F, Cameron PU, Purcell DJ, Zaunders JJ, Grey P, Bloch M, Smith D, Cooper DA, Kelleher AD.

J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):140-47.

PMID: 18300365 [PubMed - indexed for MEDLINE]

Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl.

DART Trial Team.

AIDS. 2008 Jan 11;22(2):237-47.

PMID: 18097226 [PubMed - indexed for MEDLINE]

Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection.

Nüesch R, Ananworanich J, Srasuebkul P, Chetchotisakd P, Prasithsirikul W, Klinbuayam W, Mahanontharit A, Jupimai T, Ruxrungtham K, Hirschel B.

AIDS. 2008 Jan 2;22(1):152-4.

PMID: 18090405 [PubMed - indexed for MEDLINE]

Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanita-Pulsed Antiretroviral Therapy (ISS-PART) study.

Palmisano L, Giuliano M, Bucciardini R, Fragola V, Andreotti M, Galluzzo C, Pirillo MF, Weimer LE, Arcieri R, Germinario EA, Amici R, Mancini MG, Monforte A, Castelli F, Caramello P, Vella S; Italian ISS-PART Clinical Centers.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):39-47.

PMID: 17972364 [PubMed - indexed for MEDLINE]

Effects of structured treatment interruptions on metabolic, anthropometric, immunologic, and quality of life outcomes in HIV-positive adults on HAART.

Maserati R, Foli A, Tomasoni L, Sighinolfi L, Maggiolo F, Sacchini D, Di Pietro M, Bertelli D, Tinelli C, Lori F.

Curr HIV Res. 2007 May;5(3):337-43.

PMID: 17504175 [PubMed - indexed for MEDLINE]

Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.

Jacobson JM, Pat Bucy R, Spritzler J, Saag MS, Eron JJ Jr, Coombs RW, Wang R, Fox L, Johnson VA, Cu-Uvin S, Cohn SE, Mildvan D, O'Neill D, Janik J, Purdue L, O'Connor DK, Vita CD, Frank I; National Institute of Allergy and Infectious Diseases-AIDS Clinical Trials Group 5068 Protocol Team.

J Infect Dis. 2006 Sep 1;194(5):623-32. Epub 2006 Aug 1.

PMID: 16897661 [PubMed - indexed for MEDLINE]

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.

Pai NP, Lawrence J, Reingold AL, Tulsky JP.

Cochrane Database Syst Rev. 2006 Jul 19;3:CD006148. Review.

PMID: 16856117 [PubMed - indexed for MEDLINE]

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.

Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholié S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group.

Lancet. 2006 Jun 17;367(9527):1981-9.

PMID: 16782488 [PubMed - indexed for MEDLINE]

10:

The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: final results from a randomized clinical trial (Pulse).

Bloch MT, Smith DE, Quan D, Kaldor JM, Zaunders JJ, Petoumenos K, Irvine K, Law M, Grey P, Finlayson RJ, McFarlane R, Kelleher AD, Carr A, Cooper DA.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):192-202.

PMID: 16688094 [PubMed - indexed for MEDLINE]

11:

Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.

Papasavvas E, Kostman JR, Mounzer K, Grant RM, Gross R, Gallo C, Azzoni L, Foulkes A, Thiel B, Pistilli M, Mackiewicz A, Shull J, Montaner LJ.

PLoS Med. 2004 Dec;1(3):e64. Epub 2004 Dec 28.

PMID: 15630469 [PubMed - indexed for MEDLINE]

Recent Activity